TY - JOUR
T1 - Erratum: Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction (Arthritis Rheum (2005) 53: 5 (703 709) DOI: 10.1002/art.21445)
AU - Landewe, R. B.
AU - van der Heijde, D.
AU - Dougados, M.
PY - 2020/9/1
Y1 - 2020/9/1
N2 - Landewe RB, van der Heijde D, Dougados M, et al. Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction. Ann of Rheum Dis 2020;79:920 8 A citation to the following paper should be included after first mention of the copyrighted SPARCC instrument: Maksymowych WP, et al. Spondyloarthritis Research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis. Arthritis Rheum 2005;53(5):703 9. doi: 10.1002/art.21445.
AB - Landewe RB, van der Heijde D, Dougados M, et al. Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction. Ann of Rheum Dis 2020;79:920 8 A citation to the following paper should be included after first mention of the copyrighted SPARCC instrument: Maksymowych WP, et al. Spondyloarthritis Research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis. Arthritis Rheum 2005;53(5):703 9. doi: 10.1002/art.21445.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85095973292&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/32816783
U2 - https://doi.org/10.1136/annrheumdis-2019-216839corr1
DO - https://doi.org/10.1136/annrheumdis-2019-216839corr1
M3 - Erratum/Corrigendum
C2 - 32816783
SN - 0003-4967
VL - 79
JO - Annals of the rheumatic diseases
JF - Annals of the rheumatic diseases
IS - 9
M1 - 216839
ER -